Language Select
Logotipo de Varian

Press Releases

Junio 17, 2019
Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes during the closing period to the original... Read more
Junio 13, 2019
Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI), federated data sources and clinical decision support at the 19th International... Read more
Junio 12, 2019
Varian (NYSE: VAR) today announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the FlashForward™ Consortium. The Consortium... Read more
Junio 12, 2019
Varian (NYSE: VAR) will showcase and discuss its latest innovations in radiotherapy at the DEGRO 25 (German Society for Radio Oncology) meeting in Münster, Germany, June 13-16. At the core of the... Read more
Junio 11, 2019
Varian (NYSE: VAR) announced it will be showcasing its Bravos™ afterloader system for High Dose Rate (HDR) brachytherapy treatments and other advanced brachytherapy solutions at the 2019... Read more
Junio 10, 2019
Varian (NYSE: VAR) today announced it has acquired Austin, Texas-based Endocare and Hangzhou, China-based, Alicon, to expand its portfolio of multidisciplinary integrated cancer care solutions.... Read more
Junio 10, 2019
Varian (NYSE: VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon™ system. The first patient treated on the system was... Read more
Junio 07, 2019
Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center (NYPC) held a ribbon cutting event yesterday to commemorate the opening of the... Read more
Junio 07, 2019
Varian (NYSE: VAR) today announced it will be hosting its second FlashForward™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58th annual Particle Therapy Co-Operative Group meeting... Read more
Junio 06, 2019
Varian (NYSE: VAR) announced it will be showcasing its new ProBeam® 360° proton therapy system*, June 12th-15th in Manchester, United Kingdom at the 58th PTCOG Conference (Particle Therapy... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com